Understanding how cadmium exposure leads to prostate cancer
Elucidating the molecular signaling of Cadmium Carcinogenesis
This study is looking at how exposure to cadmium, a harmful substance, might affect the development of prostate cancer, especially certain aggressive types, to help us understand how it works and what genes might be involved.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Texas A&m University Health Science Ctr NIH-funded |
| Lab location | 1 site (College Station, United States) |
| Project ID | NIH-10808061 on NIH RePORTER |
What this research studies
This research investigates the effects of cadmium, a known carcinogen, on the development of prostate cancer. It focuses on how cadmium exposure influences different types of prostate malignancies, particularly squamous cell carcinoma and poorly differentiated carcinoma, by studying both laboratory models and clinical specimens. The researchers aim to uncover the molecular mechanisms involved, including the role of specific genes that may contribute to cancer progression. By analyzing how cadmium interacts with prostate cells, the study seeks to provide insights into the pathobiology of prostate cancer.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with a history of cadmium exposure or those diagnosed with prostate cancer.
Not a fit: Patients without any history of cadmium exposure or those with other types of cancer unrelated to prostate cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to better understanding and potential prevention strategies for prostate cancer linked to cadmium exposure.
How similar studies have performed: Previous research has shown that understanding the molecular mechanisms of carcinogens can lead to significant advancements in cancer prevention and treatment.
Where this research is happening
College Station, United States
- Texas A&m University Health Science Ctr — College Station, United States (Active)
Researchers
- Principal investigator: Damodaran, Chendil — Texas A&m University Health Science Ctr
- Study coordinator: Damodaran, Chendil
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.